GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:GS71 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Dec 24	Buy€23,809	Jonathan Symonds	Individual	1,500	€15.87
20 Dec 24	Buy€8,692	Wendy Mira Becker	Individual	546	€15.92
30 Oct 24	Buy€119,322	Jonathan Symonds	Individual	7,150	€16.69
20 Jun 24	Buy€38,196	Jonathan Symonds	Individual	2,000	€19.10
20 Jun 24	Buy€8,512	Wendy Mira Becker	Individual	446	€19.09

Insider Trading Volume

Insider Buying: GS71 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GS71?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,568,617	0.0384%
Individual Insiders	3,481,659	0.0853%
State or Government	7,082,572	0.174%
Private Companies	51,831,200	1.27%
Employee Share Scheme	72,499,396	1.78%
General Public	446,530,876	10.9%
Institutions	3,497,538,259	85.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 51.8% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.12%	Dodge & Cox	372,141,692	€6.3b	0.1%	2.09%
8.81%	BlackRock, Inc.	359,298,257	€6.0b	5.9%	0.1%
4.76%	The Vanguard Group, Inc.	194,392,894	€3.3b	0.86%	0.05%
2.38%	State Street Global Advisors, Inc.	97,181,641	€1.6b	6.72%	0.06%
1.9%	UBS Asset Management AG	77,346,086	€1.3b	4.55%	0.13%
1.89%	FMR LLC	77,184,451	€1.3b	-15.1%	0.07%
1.89%	Legal & General Investment Management Limited	77,090,124	€1.3b	-5.85%	0.23%
1.82%	Norges Bank Investment Management	74,389,037	€1.3b	-5.46%	0.1%
1.78%	GlaxoSmithKline Employee Trust	72,499,396	€1.2b	-0.47%	no data
1.69%	Wellington Management Group LLP	69,160,266	€1.2b	-13.4%	0.18%
1.53%	Schroder Investment Management Limited	62,329,985	€1.0b	-22.6%	0.67%
1.5%	HSBC Global Asset Management (UK) Limited	61,405,187	€1.0b	48.5%	0.43%
1.48%	Silchester International Investors LLP	60,263,863	€1.0b	22.7%	4.03%
1.33%	Mondrian Investment Partners Limited	54,248,829	€911.8m	16.9%	6.16%
1.11%	GlaxoSmithKline plc, Shareview Client	45,089,818	€757.9m	-2.47%	no data
1%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	40,649,440	€683.3m	-0.99%	17.63%
0.99%	Fisher Asset Management, LLC	40,570,368	€681.9m	0.13%	0.28%
0.95%	Aviva Investors Global Services Ltd.	38,784,715	€651.9m	-3.07%	0.86%
0.88%	Independent Franchise Partners, LLP	35,781,530	€601.4m	70.6%	4.04%
0.88%	Columbia Management Investment Advisers, LLC	35,733,896	€600.6m	8.46%	0.13%
0.86%	BNY Asset Management	35,267,492	€592.8m	23.4%	0.11%
0.82%	Causeway Capital Management LLC	33,617,011	€565.1m	49%	2.29%
0.82%	Amundi Asset Management SAS	33,322,031	€560.1m	19%	0.11%
0.81%	Strategic Advisers LLC	33,201,948	€558.1m	-2.49%	0.21%
0.8%	Franklin Resources, Inc.	32,692,081	€549.5m	9.33%	0.19%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/02 07:37
End of Day Share Price	2025/01/31 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GSK plc is covered by 64 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kamla Singh	AlphaValue
John Eade	Argus Research Company
Odile Rundquist	Baader Helvea Equity Research